Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy
- 1 November 2021
- journal article
- conference paper
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 162 (5) , 1404-1412.e2
Abstract
No abstract availableKeywords
Funding Information
- University of Texas MD Anderson Cancer Center
This publication has 18 references indexed in Scilit:
- Signet ring cell adenocarcinomas: Different clinical–pathological characteristics of oesophageal and gastric locationsEuropean Journal of Surgical Oncology, 2014
- Signet Ring Cells in Esophageal and Gastroesophageal Junction Carcinomas Have a More Aggressive Biological BehaviorAnnals of Surgery, 2014
- Signet Ring Cells in Esophageal Adenocarcinoma Predict Poor Response to Preoperative ChemoradiationThe Annals of Thoracic Surgery, 2014
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Is Preoperative Chemotherapy Followed by Surgery the Appropriate Treatment for Signet Ring Cell Containing Adenocarcinomas of the Esophagogastric Junction and Stomach?Annals of Surgical Oncology, 2014
- The Impact of Preoperative Radiochemotherapy on Survival in Advanced Esophagogastric Junction Signet Ring Cell AdenocarcinomaThe Annals of Thoracic Surgery, 2014
- Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002BMC Cancer, 2013
- Prognostic implications of signet ring cell histology in esophageal adenocarcinomaCancer, 2013
- Signet-Ring Cell or Mucinous Histology after Preoperative Chemoradiation and Survival in Patients with Esophageal or Esophagogastric Junction AdenocarcinomaClinical Cancer Research, 2005
- Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationCancer, 2005